This inventor holds 2 USPTO granted patents. Top assignee: Inmunologia Y Genetica Aplicada, S.a.. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: Antonio Sanz Fernandez: Innovator in Recombinant Protein Technology
Introduction
Antonio Sanz Fernandez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins for diagnostic purposes. With a total of 2 patents, his work has implications for the diagnosis of porcine reproductive and respiratory syndrome virus (PRRSV).
Latest Patents
Antonio's latest patents include a method and kit using recombinant proteins in the fusion of PRRSV for diagnosis. The recombinant fusion proteins he developed comprise the protein of the nucleocapsid of PRRSV, obtained from both European and American isolates. These proteins are fused to a sequence of amino acids derived from the expression system chosen for the recombinant fusion protein. This innovative approach enhances the diagnostic capabilities for PRRSV, making it a valuable tool in veterinary medicine.
Another significant patent by Antonio focuses on recombinant proteins for the fusion of PRRSV and their use in diagnosis. Similar to his previous work, this patent emphasizes the importance of using both European and American isolates of PRRSV. The fusion proteins are designed to improve the accuracy and efficiency of PRRSV diagnosis, showcasing Antonio's commitment to advancing veterinary diagnostics.
Career Highlights
Antonio Sanz Fernandez is associated with Inmunología y Genética Aplicada, S.A., where he continues to push the boundaries of research in immunology and genetics. His work has not only contributed to scientific knowledge but has also had practical applications in the field of animal health.
Collaborations
Antonio collaborates with esteemed colleagues such as Jose Ignacio Casal Alvarez and Ma Jose Rodriguez Garcia. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Antonio Sanz Fernandez stands out as an innovator in the field of recombinant protein technology. His patents and ongoing research contribute significantly to the diagnosis of PRRSV, reflecting his dedication to improving animal health through scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile